Stock Pick

[Entidi]

chitra

[Entidi]

ee ghoram chusava? 

[Kickuu]

ee ghoram chusava? 

Lol.1q Lol.1q Lol.1q

[Nidhi90]

LoL.1q LoL.1q LoL.1q

 

wht so funny?

 

[Kickuu]

wht so funny?

Mee Creating CJJD....Appudu seftha

[Nidhi90]

Mee Creating CJJD....Appudu seftha

 

sure @3$% @3$%

[mavrick4]

Emindi AMRN ki sudden ga perigindi ????

[mavrick4]

Edho approve ayyindi AntA koneyocha AMRN....

[idiBeZaWaDa]

Edho approve ayyindi AntA koneyocha AMRN....

sarigga news saduv mundu...endi approve ayyedi bokka..

[idiBeZaWaDa]

JHat man...AKRX ammesi AMBA konu..already profitlo unnav..malli enter avochu

[sandie]

Edho approve ayyindi AntA koneyocha AMRN....

 

 

Amarin confirms that a federal district judge has granted its motion for summary judgment in the company's lawsuit against the US FDA (AMRN) : Co believes based on the court's ruling that Vascepa is entitled to five-year marketing exclusivity starting from FDA's approval of Vascepa in July 2012, thus extending NCE exclusivity through July 25, 2017. 

• The ruling also confirms that acceptance by FDA of abbreviated new drug applications for generic versions of Vascepa is not permitted until July 2016. 
• The related statutory 30-month stay triggered by patent litigation following generic application resubmissions in July 2016 would then expire in January 2020

[sandie]

Good Morning Ppl

 

My two lil diamonds MVIS, BIOC  premarket eee moved ^^ ^^ bl@st bl@st bl@st

 

 

sooo sweet

[idiBeZaWaDa]

 

Amarin confirms that a federal district judge has granted its motion for summary judgment in the company's lawsuit against the US FDA (AMRN) : Co believes based on the court's ruling that Vascepa is entitled to five-year marketing exclusivity starting from FDA's approval of Vascepa in July 2012, thus extending NCE exclusivity through July 25, 2017. 

• The ruling also confirms that acceptance by FDA of abbreviated new drug applications for generic versions of Vascepa is not permitted until July 2016. 
• The related statutory 30-month stay triggered by patent litigation following generic application resubmissions in July 2016 would then expire in January 2020

 

denni approve avvadam antara...

[sandie]

denni approve avvadam antara...

 

paina Approval vachindhani.. anukunnaru..  andhuke post chesaa... Tempry Raise ee adhi ani cheppataniki

 

 aa mathramm theleitledhaa  meku   :o

[idiBeZaWaDa]

paina Approval vachindhani.. anukunnaru..  andhuke post chesaa... Tempry Raise ee adhi ani cheppataniki

 

 aa mathramm theleitledhaa  meku   :o

teleedu...meeru septhiri kada...iffude telsindi..